How to Actually Clear Acne, Eczema and Rosacea

This is the third post in our series on the gut–skin axis. In part one, we explored the science of why gut health determines skin health — the immune pathways, the microbial metabolites, and the mechanisms by which dysbiosis drives acne, eczema, rosacea, and psoriasis. In part two, we looked at the warning signs that your gut is involved: the cluster of symptoms that, when read together, point toward a gut-driven skin condition. If you recognised yourself in either of those posts, this one is for you. The most important question is not why — it is what do I actually do? So in this blog I am going to walk you through how to actually clear acne, eczema and rosacea.

Why Single-Layer Approaches Often Fall Short

Before exploring what works, it’s worth understanding why so many reasonable-sounding approaches produce disappointing results in isolation.

Probiotics alone. The evidence for probiotics in skin conditions is real but modest and highly strain-dependent. A 2025 meta-analysis in Medicina (Tjiu and Lu) found a statistically significant but modest reduction in inflammatory lesion counts in acne, with substantial heterogeneity between studies. A separate 2025 meta-analysis in Cureus (Mohamed et al.) found similar improvements but noted that variations in strain, duration, and participant demographics led to divergent findings. The evidence is there — but a generic probiotic taken without addressing diet, gut barrier integrity, or identified dysbiosis is unlikely to produce the sustained change most people are hoping for.

Elimination diets alone. Removing a trigger food can reduce symptoms, but it does not repair the gut barrier that allowed that food antigen to provoke an immune response in the first place. Without restoring gut integrity, the immune system remains sensitised and new sensitivities can develop. Patients who have progressively eliminated ten or more foods and are still experiencing flares often find that the problem was never the foods — it was the compromised barrier.

Topicals alone. Topical treatments address downstream expression, not upstream cause. Steroid creams reduce surface inflammation. Retinoids alter keratinocyte turnover. Antibiotics modify the skin microbiome. None of these interventions address gut dysbiosis, restore intestinal barrier function, or shift the immune imbalance driving the inflammatory cycle. When treatment stops, the cycle often resumes — because nothing in the gut has changed.

The reason these approaches underperform in isolation is the same: they address one layer of a multi-layer problem. The gut–skin axis is a system — and treating a system requires a layered approach that addresses each relevant driver in a sequence that makes biological sense.

Is Your Gut Causing Skin Issues?

Shop our gut tests

The Layered Gut Health Approach

The approach described here moves through four interconnected layers. In practice, the order matters. You cannot effectively re-seed a healthy microbiome into a gut environment that is still inflamed, nor can you sustain bacterial diversity without the dietary foundation to support it.

Layer 1: Test, Don’t Guess

The single most important shift a person with a chronic gut-driven skin condition can make is to move from trial-and-error interventions to evidence-based ones. That requires knowing what is actually happening in their gut.

Comprehensive microbiome testing, like out Ultimate Gut Health Test, gives a detailed picture of microbial diversity, the presence and abundance of key anti-inflammatory species (notably Faecalibacterium prausnitzii and Akkermansia muciniphila), the presence of pathogenic or dysbiotic organisms, markers of gut immune activation, and intestinal permeability via zonulin. This is not about diagnosing a disease. It is about understanding the specific pattern of disruption that is driving your particular skin picture, so that dietary and supplemental interventions can be targeted rather than generic.

For patients where rosacea, perioral dermatitis, or acne coexist with digestive symptoms — bloating, altered bowel habits, post-meal discomfort — SIBO breath testing adds another dimension. Small intestinal bacterial overgrowth, and its methanogen-producing counterpart IMO, are specifically associated with rosacea pathophysiology, as we will explore in the fourth post in this series.

The clinical value of testing is specificity. Two patients with eczema may have entirely different microbial profiles driving their skin. One may have depleted Faecalibacterium prausnitzii and low butyrate production. Another may have elevated histamine-producing bacteria and suppressed DAO activity. The appropriate interventions for each are meaningfully different. Testing makes the difference between a protocol that is individually targeted and one that is generalised.

Layer 2: Build the Dietary Foundation

Targeted supplementation and probiotics are most effective when built on a genuine dietary foundation. Without it, you are trying to restore a microbiome ecosystem while continuing to remove the conditions it needs to thrive.

The Mediterranean Pattern: RCT Evidence for Skin

The Mediterranean dietary pattern — characterised by abundant plant foods, extra virgin olive oil, oily fish, legumes, wholegrains, nuts, and moderate quantities of lean meat, with limited processed foods, refined sugars, and alcohol — is the best-evidenced dietary template for the gut–skin axis. In 2025, it received the strongest clinical validation it has yet seen in a skin-specific context.

The MEDIPSO trial (Perez-Bootello et al., JAMA Dermatology, 2025) was the first randomised clinical trial to test the Mediterranean diet directly in psoriasis patients. Adults with mild to moderate psoriasis on stable topical therapy were randomised to a 16-week dietitian-guided Mediterranean diet programme or standard low-fat dietary advice. The Mediterranean diet intervention significantly improved psoriasis severity as measured by the Psoriasis Area and Severity Index (PASI). Participants in the intervention group also reported better sleep quality, reduced anxiety, and improved quality of life.[3] This is landmark evidence: not just an observational association, but a randomised trial demonstrating the dietary impact on skin disease severity.

For rosacea, a large prospective cohort study found that each one-point increment in Mediterranean diet score was associated with a 16% reduction in the risk of incident rosacea over four years of follow-up.[4] For acne, a 2025 review in Nutrition & Metabolism (Taha et al.) found that higher adherence to the Mediterranean diet was consistently associated with lower acne prevalence and severity, in contrast to high-glycaemic and Western dietary patterns, which are associated with worse outcomes.[5]

The mechanisms are precisely those we would predict from the gut–skin axis research. The Mediterranean diet increases SCFA-producing bacteria, reduces systemic LPS and inflammatory cytokine production, improves gut barrier integrity, and provides antioxidant polyphenols and omega-3 fatty acids that reduce both gut and cutaneous inflammation.

Plant Diversity: The Single Most Impactful Dietary Habit

Within any dietary pattern, the most important gut health habit is maximising the diversity of plant foods consumed each week. Research consistently shows that eating 30 or more different plant foods per week is associated with significantly greater gut microbial diversity, higher SCFA production, and lower intestinal permeability than eating fewer than 10.[6]

This is not about any single superfood. It is about diversity — different vegetables, fruits, legumes, wholegrains, nuts, seeds, herbs, and spices, each feeding different microbial populations and collectively building the ecological complexity that underlies a healthy, resilient microbiome. For patients rebuilding after dysbiosis, working systematically toward 30 plants per week is the most impactful dietary change they can make.

What to Minimise

Certain dietary patterns are consistently pro-dysbiotic and pro-inflammatory in the gut–skin axis literature:

High-glycaemic foods and refined sugars activate mTORC1 signalling, drive sebum overproduction, and elevate IGF-1 — mechanisms directly relevant to acne pathogenesis. They also reduce microbial diversity and promote inflammatory dysbiosis.[5,6]

Alcohol disrupts tight junction integrity, promotes gut permeability, and alters microbial composition — a significant factor in why many patients notice skin flares after alcohol-containing meals and events.

Ultra-processed foods are associated with reduced microbial diversity, elevated LPS production, and increased systemic inflammation — the precise combination that drives chronic inflammatory skin conditions.

Layer 3: Repair the Gut Barrier

Diet creates the ecological conditions for a healthy microbiome. But where the gut barrier has been structurally compromised, targeted nutritional support can accelerate repair in ways that diet alone cannot fully achieve in a reasonable timeframe.

Sodium Butyrate

Butyrate is the most clinically important of the short-chain fatty acids for both gut and skin health. It is the primary fuel source for colonocytes, directly strengthens tight junction proteins, suppresses NF-κB-mediated gut inflammation, and supports the development of regulatory T cells that reduce cutaneous inflammatory responses. Research published in Gut Microbes demonstrated that butyrate supports skin barrier function by directly shaping keratinocyte metabolism and driving a mitochondria-dependent differentiation programme. [6] Sodium butyrate supplementation is particularly relevant for patients with measurable dysbiosis who may not be producing sufficient butyrate from dietary fibre — which is common in the early stages of gut restoration, before prebiotic-feeding bacteria have been restored.

Research published in Gut Microbes (Mahmud et al., 2022) confirmed that sodium butyrate is used clinically in hyperproliferative skin diseases including psoriasis, modulating key cellular processes including differentiation, proliferation, and apoptosis.[7]

Recommended product: Sodium Butyrate

L-Glutamine

L-Glutamine is the primary fuel for intestinal epithelial cells and plays a central role in maintaining tight junction integrity. It is conditionally essential under conditions of gut stress, inflammation, or dysbiosis — meaning that while the body can synthesise it under normal circumstances, demand can exceed synthesis in patients with compromised gut barriers. Supplemental L-glutamine provides direct substrate for enterocyte repair and has been shown to support intestinal permeability in clinical contexts.

Recommended product: Rezcue

Zinc

It is essential for the structural integrity of tight junction proteins, the regulation of inflammatory cytokines, and the activity of antimicrobial peptides in both the gut and skin. A deficiency is associated with impaired gut barrier function, increased intestinal permeability, and — at the skin level — perioral dermatitis, acne, and alopecia.[8] Supplementation is relevant for patients with malabsorption patterns, restricted diets, or measurable zinc insufficiency.

Recommended Product: Zinc&Copper

Layer 4: Reseed and Support the Microbiome

With the dietary foundation in place and gut barrier repair underway, targeted microbial restoration becomes both possible and effective. This is the layer where probiotics, prebiotics, and postbiotics come in — not as first-line interventions in isolation, but as precision tools built on the work done in layers 1 to 3.

Probiotics: Why Strain Selection Matters

The probiotic evidence for skin conditions is strongest and most consistent for atopic dermatitis. A 2025 systematic review and meta-analysis in Microorganisms (Lagkouvardos et al.) examined RCTs of microbial interventions in atopic dermatitis and found significant improvements in SCORAD scores with probiotic supplementation. Multistrain formulations produced more consistent results than single-strain products.[9]

For acne, as noted above, pooled RCT data show a modest but statistically significant reduction in inflammatory lesions with oral probiotics — with results most likely reflecting strain-specific effects, since heterogeneity between trials is high.[1,2] Strains with the most clinical evidence in acne include Lactobacillus rhamnosus SP1, Lactobacillus acidophilus, and Bifidobacterium species.

For rosacea, the picture is compelling but requires integration with SIBO management (covered in our next post). A 2025 review in Biomolecules (Manfredini et al.) examining probiotics and diet in rosacea concluded that probiotic supplementation — particularly Lactobacillus species — reduced erythema and inflammatory lesions, with effects attributed to modulation of the gut–skin axis, reduction of systemic inflammation, and restoration of gut barrier integrity.[10]

What the evidence does not support is the use of generic, off-the-shelf probiotics without reference to clinical need. Strain selection matters. Dosage matters. Duration matters — most trials showing meaningful skin outcomes ran for 8–12 weeks minimum. And probiotics taken into a gut environment that is still inflamed, permeability-compromised, and nutritionally unsupported will have limited ecological impact.

Choose probiotic formulations with documented clinical evidence for your specific skin condition, at therapeutic doses (generally ≥10 billion CFU), for a minimum of 8–12 weeks — ideally guided by what your microbiome testing has revealed about the specific species most depleted.

Prebiotics: Feeding What You Are Planting

Probiotics introduce beneficial bacteria. Prebiotics feed them — and feed the indigenous SCFA-producing populations already present. Prebiotic fibres, including inulin, fructooligosaccharides (FOS), and galactooligosaccharides (GOS), PHGG, are fermented by beneficial bacteria to produce butyrate, propionate, and acetate. In a study examining GOS with Bifidobacterium, the combination reduced trans-epidermal water loss (TEWL) and skin erythema — demonstrating direct gut-to-skin effects from prebiotic supplementation.[7]

The most accessible and cost-effective prebiotic strategy is dietary: garlic, onions, leeks, asparagus, Jerusalem artichokes, chicory, bananas, and oats all contain significant prebiotic fibre content. For patients with active SIBO, prebiotic fibre may initially worsen bloating — which is one of many reasons testing and sequencing matter in this approach.

Omega-3 Fatty Acids: Supporting Both Gut and Skin

Omega-3 fatty acids (EPA and DHA, from oily fish and fish oil) have a dual role in the gut–skin axis. At the gut level, they reduce intestinal inflammation, support tight junction integrity, and support the microbiome toward anti-inflammatory taxa. At the skin level, they reduce the production of pro-inflammatory cytokines (IL-1β, TNF-α, IL-6), support the skin lipid barrier, and are associated with reduced severity in atopic dermatitis and psoriasis.[6] In clinical practice, omega-3 supplementation is considered a core part of the gut–skin axis protocol — not a peripheral adjunct.

Recommended product: Life & Soul

Curcumin and Polyphenols

High-bioavailability curcumin, and polyphenols more broadly, have documented effects at multiple levels of the gut–skin axis. They support the gut microbiome toward greater diversity, reduce gut mucosal inflammation, support tight junction integrity, and have been shown to inhibit the NF-κB inflammatory pathway associated with acne, eczema, psoriasis, and rosacea.[6,7] The MEDIPSO trial specifically attributed part of the Mediterranean diet’s benefits to its richness in polyphenols — vitamins A, C, and E alongside plant-derived compounds that support immune regulation and reduce oxidative stress.[3]

Recommended product: Curcumin

What the Layered Approach Looks Like in Practice

The framework above translates into a clinical sequence that looks something like this:

Weeks 1–4 — Assess and build the foundation. Test first: gut microbiome analysis and, where indicated, SIBO breath testing. Simultaneously begin the dietary foundation — moving toward a Mediterranean pattern, prioritising plant diversity, and reducing the primary pro-dysbiotic inputs (refined sugars, alcohol, ultra-processed foods). Begin gut barrier support: L-glutamine, sodium butyrate, zinc. These do not require test results to start — their safety profile is high and their role in barrier repair is broadly applicable.

Weeks 4–8 — Targeted microbial restoration. With test results available, introduce probiotics targeted to your specific pattern of dysbiosis — selected for documented evidence in your skin condition and relevant to the bacterial species most depleted in your microbiome analysis (this will be doen for you by a qualified nutritional therapist at Healthpath when you order the Ultimate Gut Health Test Plan) . Ensure dietary diversity is consistently supporting prebiotic fibre intake. Add omega-3 supplementation and curcumin.

Weeks 8–16 — Sustain and refine. Meaningful change in the gut microbiome and gut barrier integrity requires consistent intervention over a minimum of 8–12 weeks. Reassess skin outcomes at 8 and 12 weeks. If SIBO was identified, this is typically when eradication protocols are completed and post-eradication microbiome support is commenced. Refine the dietary approach based on how the gut and skin are responding.

What Role Does Lifestyle Play: Sleep, Stress, and Exercise

No gut–skin protocol is complete without addressing the lifestyle pillars that regulate the gut microbiome as powerfully as diet and supplements do.

Sleep is foundational. A single night of sleep deprivation measurably increases intestinal permeability and reduces microbial diversity. Chronic poor sleep is associated with elevated cortisol, increased intestinal LPS translocation, and worsened skin barrier function. In this framework, sleep is a gut health intervention.

Stress management works through the HPA axis and gut–brain axis. Chronic stress elevates corticotropin-releasing hormone in the gut, directly disrupting tight junction proteins and suppressing beneficial Lactobacillus and Bifidobacterium species. A 2024 review in the American Journal of Lifestyle Medicine (Do) demonstrated that the lifestyle pillars influencing the gut microbiome — diet, exercise, sleep, and stress management — are the fundamental targets for supporting skin health at a systems level.[11]

Exercise at moderate intensity increases SCFA-producing bacterial abundance, reduces intestinal permeability, and lowers systemic inflammatory markers. Excessive high-intensity exercise without adequate recovery can have the opposite effect — temporarily increasing gut permeability and inflammatory load — which is relevant for patients whose skin reliably flares after very intense training periods.

Why This Approach Works When Others Have Not

The layered approach described here works not because it is more complicated than the alternatives — but because it matches the complexity of what is actually causing the problem.

Chronic inflammatory skin conditions driven by gut dysbiosis are systems-biology problems. They involve the microbiome, the gut barrier, the immune system, the neuroendocrine axis, and the skin simultaneously. They are sustained by multiple drivers operating in concert. Addressing them requires tackling those drivers together — not one at a time, in isolation, and not for four weeks before concluding that the gut approach did not work.

The MEDIPSO trial, the probiotic meta-analyses, the gut barrier restoration literature, and a growing body of clinical evidence all point to the same conclusion: when the approach is appropriately layered — when diet, barrier repair, microbial restoration, and lifestyle are addressed together, in a sequence that makes biological sense — meaningful and sustained improvement in acne, eczema, rosacea, and other gut-driven skin conditions is achievable.

In the final post in this series, we explore SIBO: what the research shows about its role in rosacea, perioral dermatitis, and other conditions, how it is diagnosed, and what treatment approaches the evidence supports.

---

References

1. Tjiu JW, Lu CF. Oral probiotics in Acne vulgaris: a systematic review and meta-analysis of double-blind randomized clinical trials. Medicina. 2025;61(12):2152. doi:10.3390/medicina61122152
2. Mohamed A, et al. The impact of probiotics on acne vulgaris: a meta-analysis of randomized controlled trials. Cureus. 2025;17(11):e97010. doi:10.7759/cureus.97010
3. Perez-Bootello J, Berna-Rico E, Abbad-Jaime de Aragon C, et al. Mediterranean diet and patients with psoriasis: the MEDIPSO randomized clinical trial. JAMA Dermatol. 2025;161(12):1215–1223. doi:10.1001/jamadermatol.2025.3410
4. Gu Y, et al. Associations of adherence to Mediterranean-like diet pattern with incident rosacea: a prospective cohort study of government employees in China. Front Nutr. 2023;10:1092781. doi:10.3389/fnut.2023.1092781
5. Taha N, et al. The Mediterranean diet and acne vulgaris. Nutr Metab. 2025;22:132. doi:10.1186/s12986-025-01033-9
6. Jimenez-Sanchez M, Celiberto LS, Yang H, Sham HP, Vallance BA. The gut-skin axis: a bi-directional, microbiota-driven relationship with therapeutic potential. Gut Microbes. 2025;17(1):2473524. doi:10.1080/19490976.2025.2473524
7. Mahmud MDR, Akter S, Tamanna SK, et al. Impact of gut microbiome on skin health: gut-skin axis observed through the lenses of therapeutics and skin diseases. Gut Microbes. 2022;14(1):e2096995. doi:10.1080/19490976.2022.2096995
8. Singla N, Singla K, Attauabi M, Aggarwal D. Gut-skin axis: emerging insights for gastroenterologists — a narrative review. World J Gastrointest Pathophysiol. 2025;16(3):108952. doi:10.4291/wjgp.v16.i3.108952
9. Lagkouvardos I, et al. Microbial interventions for inflammatory skin diseases: a systematic review and meta-analysis of atopic dermatitis and psoriasis. Microorganisms. 2025;13(11):2416. doi:10.3390/microorganisms13112416
10. Manfredini M, Barbieri M, Milandri M, Longo C. Probiotics and diet in rosacea: current evidence and future perspectives. Biomolecules. 2025;15:411. doi:10.3390/biom15030411
11. Do NM. From leaky gut to leaky skin: a clinical review of lifestyle influences on the microbiome. Am J Lifestyle Med. 2024. doi:10.1177/15598276241292605